Given the overexpression of MCP‐1 in basal‐like breast cancers that are ER−, we hypothesised that high MCP‐1 expression in the primary tumour of ER− breast cancers would be correlated with a greater incidence of distant relapse and decreased survival. The gene discussed is CCL2; the disease is neoplasm.